Estrogen receptor modulators
    4.
    发明申请
    Estrogen receptor modulators 有权
    雌激素受体调节剂

    公开(公告)号:US20050234245A1

    公开(公告)日:2005-10-20

    申请号:US10512172

    申请日:2003-04-18

    CPC分类号: C07D327/06

    摘要: The present invention relates to compounds and derivatives thereof, their cynthesis, and their use as estrogen receptor modulators. The compound of the instant invention are ligands for estrogen receptors and as such may be useful for treatment or prevention of a variety of conditions related to estrogen functioning including: bone loss, bone fractures, osteoporosis, cartilage degeneration, endometriosis, uterine fibroid desease, hot flashes, increased levels of LDL cholestterol, cardiovascular disease, impairment of cognitive functioning, cerebral degenerative disorders, restenosis, gynecomastia, vascular smooth muschle cell proliferation, obesity, incontinence, and cancer, in particular of the breast, uterus and prostate.

    摘要翻译: 本发明涉及其化合物及其衍生物,它们的胞质和它们作为雌激素受体调节剂的用途。 本发明的化合物是雌激素受体的配体,因此可用于治疗或预防与雌激素功能相关的各种病症,包括:骨丢失,骨折,骨质疏松,软骨退化,子宫内膜异位症,子宫肌瘤病,热 乳酸,子宫和前列腺的LDL胆固醇水平升高,心血管疾病,认知功能障碍,脑退行性疾病,再狭窄,男子乳腺发育,血管平滑肌细胞增殖,肥胖症,失禁和癌症。